ALMS vs XENE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 18, 2026

ALMS

64.7
AI Score
VS
ALMS Wins

XENE

56.5
AI Score

Investment Advisor Scores

ALMS

65score
Recommendation
BUY

XENE

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ALMS XENE Winner
Revenue 3.40M 264,000 ALMS
Net Income -235.27M -22.64M XENE
Net Margin -6913.7% -8575.4% ALMS
Operating Income -247.26M -24.52M XENE
ROE -52.0% -52.3% ALMS
ROA -42.0% -48.8% ALMS
Total Assets 560.62M 46.36M ALMS
Cash 63.71M 14.69M ALMS
Free Cash Flow -168.98M -22.14M XENE

Relative Price Performance (Last 90 Days)

ALMS 1M: -14.6% · 3M: +9.0% XENE 1M: -7.1% · 3M: +12.3%

Current Technical Phase

ALMS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.2 · Price: $24.17

XENE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.3 · Price: $60.77

Fundamentals Snapshot

Metric ALMS XENE
Market Cap
Forward P/E -8.4 -12.3
Trailing P/E
Revenue (TTM)
Revenue Growth -0.4% -1.0%
Gross Margin 1.0%
Operating Margin -64.4% 0.0%
EPS -3.91 -4.64
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ALMS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.